Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Nebraska for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Nebraska only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Nebraska (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Samuel Mehr (NPI 1497781801)

Field	Value
Entity Type	Individual
Organization	Samuel Mehr
Address	17201 Wright St Ste 200
City	Omaha
State	NE
ZIP	68130
Taxonomy	Nuclear Medicine Physician
NPI Enumerated	June 25, 2006

Payer Source	Total Paid
Medicare	$2.5M
Medicaid	$0

Key Findings

This provider’s billings indicate a focused nuclear medicine and theranostics practice: A9607 (Lutetium lu 177 vipivotide tetraxetan) alone accounts for $1.6M in Medicare revenue and 64.7% of the provider’s Medicare receipts, and diagnostic PET/CT and gallium tracers such as 78815 and A9596 together make up much of the remainder. The code mix — A9607, 78815, A9596, plus additional radiopharmaceutical codes — is consistent with a practice that delivers both therapeutic radiopharmaceutical treatments and advanced molecular imaging.

Revenue concentration is very high: the precomputed top three Medicare codes (A9607, 78815, A9596) account for 89.0% of this provider’s total Medicare revenue, signaling that a small set of services drives the business. This concentration suggests financial sensitivity to reimbursement or access changes for those specific therapies and imaging studies.

The payer mix is effectively single-payer Medicare: lifetime Medicare revenue is $2.5M while there is no Medicaid billing on file. This means analyses of utilization and competitive positioning should be interpreted in a Medicare-dominant context rather than across a mixed commercial/Medicaid footprint.

Competitive standing varies by service. For A9607 the provider ranks #18 of 44 nationally (60th percentile; typical, unremarkable volume for this code), for 78815 the provider ranks #504 of 6566 (92th percentile; typical, unremarkable volume for this code), and for A9596 the provider ranks #36 of 168 (78th percentile; typical, unremarkable volume for this code), indicating a modest-to-strong national presence in PET imaging and gallium diagnostics but not a market-leading position in lutetium therapy.

There is a statistical outlier on an ancillary therapeutic injection code: 79101 shows 115 claims and $12.1K revenue (0.5% of Medicare revenue) with a rank of #10 of 302 nationally (97th percentile; notably above typical national volume). Despite its relatively small share of revenue, this elevated rank suggests unusually high activity in certain therapeutic radiopharmaceutical administrations compared with peers.

Operationally, the practice appears to perform in-house tracer administration and infusion services: A9587 has 1.1K claims and $65.7K revenue (2.6% of Medicare revenue), A9552 has 324 claims and $49.2K revenue (1.9%), and infusion/administration codes such as 96374 (283 claims, $7.9K) and 96360 (118 claims, $2.8K) are present. This mix supports a workflow that includes both diagnostic imaging and hands-on radiopharmaceutical delivery.

The business risk profile is concentrated around A9607: because that single code represents $1.6M and 64.7% of Medicare revenue, changes in utilization, supply, or reimbursement for A9607 would materially affect the provider’s revenue base. With the top three codes comprising 89.0% of Medicare revenue, diversification outside those therapies and PET imaging is limited in the current billing footprint.

The provider has an established Medicare billing history with an NPI enumerated on 2006-06-25 (~20 years ago), which suggests a long-tenured practice and potentially stable referral relationships. Coupled with the absence of Medicaid billing, the profile points to an experienced, Medicare-focused nuclear medicine operation serving primarily fee-for-service Medicare patients.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

27 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
A9607	Lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie	8,540	$190	$1.6M
78815	PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.…	330	$1,190	$391.4K
A9596	Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie	280	$820	$225.8K
78816	The patient is injected with a radiopharmaceutical tracer called FDG (fluoro–deoxyglucose, a radioactive substance containing glucose) about one hour before the imaging is scheduled to begin. The…	90	$1,200	$107K
A9587	Gallium ga-68, dotatate, diagnostic, 0.1 millicurie	1,130	$60	$65.7K
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	320	$150	$49.2K
79101	In this procedure, the provider injects a radiopharmaceutical substance into the venous blood stream to treat the patient’s condition.	120	$110	$12.1K
74177	The provider performs computed tomography of the abdomen and pelvis with contrast material to diagnose the cause of abdominal or pelvic pain or other abnormalities of the internal organs.	70	$160	$11.3K
96374	The provider administers a single medication or other substance rapidly into a vein to treat, prevent, or diagnose a condition.	280	$30	$7.9K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	70	$90	$6.2K

Showing 1–10 of 27

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 27 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Nebraska Distribution

Samuel Mehr — 5 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Nebraska

Full comparison — all codes billed, vs. state median

27 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
A9607	2	10	9,070	$190	$1.8M
A9596	3	10	280	$820	$243.3K
A9587	1	10	1,130	$60	$65.4K
78815	2	60	70	$380	$32.7K
74177	137	160	170	$80	$15.3K
99214	1,970	3,210	110	$70	$14.9K
A9552	1	10	70	$140	$13K
78816	2	20	20	$410	$12.7K
79101	1	10	80	$100	$8.7K
99213	2,808	3,220	90	$50	$7.9K

Showing 1–10 of 27

Related Providers

Other providers that share a Tax Identification Number (TIN) with Samuel Mehr, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
State University Of Iowa	IA	Family Medicine Physician	$0	$103.8M
Radiology Consultants PC	NE	Diagnostic Radiology Physician	$0	$10M
Thomas Buroker	IA	Medical Oncology Physician	$9.4M	$0
Robert Behrens	IA	Medical Oncology Physician	$5.2M	$0
Luke Nordquist	NE	Hematology & Oncology Physician	$3.7M	$0
Stefano Tarantolo	NE	Hematology & Oncology Physician	$3.2M	$0
Mission Cancer And Blood, PLLC	IA	Hematology & Oncology Physician	$0	$2.8M
Ralph Hauke	NE	Hematology & Oncology Physician	$2.5M	$0
Bradley Hiatt	IA	Medical Oncology Physician	$2.2M	$0
Gamini Sooriyaarachchi	FL	Medical Oncology Physician	$2.2M	$0

Nearby Providers

Other providers in the same ZIP code as Samuel Mehr, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Alegent Creighton Health	NE	General Acute Care Hospital	$0	$4.3M
Dean Arkfeld	NE	Ophthalmology Physician	$1.4M	$0
Omegavision PC	NE	Optometrist	$0	$1.4M
New Century Physicians Of Nebraska LLC	NE	Emergency Medicine Physician	$0	$917.9K
Heartland Family First Medical Clinic, LLC	NE	Pediatrics Physician	$0	$899.3K
Lakeside Ambulatory Surgical Center LLC	NE	Ambulatory Surgical Clinic/Center	$557.1K	$0
Omaha Anesthesia Associates LLC	NE	Anesthesiology Physician	$0	$517.9K
Children's Rehab - Occupational Therapy	NE	Pediatric Occupational Therapist	$0	$388.1K
Brandon Menke	NE	Ophthalmology Physician	$372.2K	$0
Beyond Care Pediatrics LLC	NE	Pediatrics Physician	$0	$354.5K

Samuel Mehr — Billing Profile & Reimbursement Data

Sign up for Samuel Mehr — Billing Profile & Reimbursement Data policy alerts

Samuel Mehr — Billing Profile & Reimbursement Data

Sign up for Samuel Mehr — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References